Literature DB >> 2515950

Mast cells: immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses.

S J Galli1, B K Wershil, J R Gordon, T R Martin.   

Abstract

Mast cells are critical effectors in many IgE-dependent responses, and the numbers and phenotype of certain mast cell populations can be influenced, through IL-3 and IL-4, by the same T cells that regulate IgE production. However, IgE can interact with cells other than mast cells, and different mast cell populations express significant variation in multiple important aspects of their phenotype, including mediator content and responses to cytokines and stimuli of activation. As a result it may be difficult to define the unique contributions of mast cells to IgE-dependent reactions. One approach for analysing the roles of various mast cell populations in individual biological responses is to attempt to elicit these reactions in mice in which the presence or absence of specific mast cell populations can be regulated experimentally. We have used genetically mast cell-deficient and mast cell-reconstituted mice to demonstrate that mast cells provide essential effector function in certain IgE-dependent responses involving the skin, stomach or lungs but are not necessary for the pulmonary alterations and death associated with active anaphylaxis. Similar approaches can be used to investigate the biological significance of the production, by mast cells stimulated with IgE and specific antigen, of cytokines similar or identical to IL-1, IL-3, IL-4, IL-5, IL-6, TNF-alpha/cachectin, IFN-gamma, GM-CSF, JE, MIP-1 alpha, MIP-1 beta and TCA3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515950     DOI: 10.1002/9780470513866.ch5

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

1.  Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.

Authors:  K Hochstrasser; G J Albrecht; W Gebhard; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

2.  Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.

Authors:  M Tsai; T Takeishi; H Thompson; K E Langley; K M Zsebo; D D Metcalfe; E N Geissler; S J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha.

Authors:  B K Wershil; Z S Wang; J R Gordon; S J Galli
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

5.  Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Authors:  Sabine Cerny-Reiterer; Anja Rabenhorst; Gabriele Stefanzl; Susanne Herndlhofer; Gregor Hoermann; Leonhard Müllauer; Sigrid Baumgartner; Christine Beham-Schmid; Wolfgang R Sperr; Christine Mannhalter; Heinz Sill; Werner Linkesch; Michel Arock; Karin Hartmann; Peter Valent
Journal:  Oncotarget       Date:  2015-02-20

6.  Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction.

Authors:  Il-Whan Choi; Young-Suk Kim; Dae-Ki Kim; Jung-Hwa Choi; Kook-Heon Seo; Shun-Young Im; Keun-Sang Kwon; Myung-Shik Lee; Tai-You Ha; Hern-Ku Lee
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.